Freezing out tumors: new hope for rare desmoid disease
NCT ID NCT02476305
First seen Jan 30, 2026 · Last updated Jun 22, 2026 · Updated 20 times
Summary
This study tested a freezing technique called cryoablation on 50 adults with desmoid tumors that had grown despite medical treatment. The goal was to stop tumor growth and ease symptoms without surgery. Researchers used MRI to guide the freezing and check results one year later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Service d'Imagerie Interventionnelle
Strasbourg, Alsace, 67091, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cryoablation (freezing therapy using cryoprobes)
What this could lead to
If successful, cryoablation could provide a non-surgical way to control desmoid tumors, reduce pain, and improve quality of life for patients who have not responded to other treatments.
What could go wrong
This is a small, early-phase study (50 participants) with no control group. The procedure may not work for all tumor locations, and there is a risk of incomplete destruction or recurrence.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.